期刊文献+

婴儿型脊肌萎缩症22例临床分析 被引量:2

Clinical analysis of 22 patients with infantile spinal muscular atrophy
下载PDF
导出
摘要 目的探讨婴儿型脊肌萎缩症的发病机制、临床与病理特征及诊断。方法对22例确诊为婴儿型脊肌萎缩症患者的临床表现、实验室资料、病理资料进行了回顾性分析。结果本病临床特点患儿大多为8个月内起病,四肢呈对称性、迟缓性瘫痪,下肢重于上肢,近端重于远端;有肌萎缩,血清CK、LDH正常或增高;肌电图显示神经源性损害,肌活检见肌纤维萎缩、变性、坏死,符合脊肌萎缩症的改变。结论婴儿型脊髓性肌萎缩症有较典型的临床及电生理特征,肌电图检查是重要的诊断方法,肌活检可为脊肌萎缩症的诊断提供客观的诊断依据,目前对本病主要采取对症治疗。 Objective To investigate the pathogenesis, diagnosis,clinical and pathological features of spinal muscular atrophy in infants. Method Twenty-two patients were retrospectively studied in term of the clinical manifestations, pathological examination and laboratory data. Results The children were ill in 8 months old, with the symptom that four limbs present symmetry and slow paralysing, and low limbs being more serious than upper limbs, the proximate being more serious than the distant of the four limbs. The level of creatine kinase(CK) and lactate dehydrogenase(LDH) in serum were normal or elevated than normal level. Electromyography demonstrated motoneuron degeneration. Muscle biopsy showed muscle fibers atrophy, degeneration and necrosis, consistent with the changes of spinal muscular atrophy. Conclusion There are unique clinical and electrophysiology features for infantile spinal muscular atrophy, and electromyography may play an important role in the diagnosis. Muscle biopsy can provide objective diagnostic evidence for spinal muscular atrophy. Recently the genetic study is developing rapidly. Symptomatic treatment is the main treatment.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2011年第1期48-49,共2页 Journal of Apoplexy and Nervous Diseases
关键词 婴儿型脊肌萎缩症 发病机制 病理 诊断 Infantile Spinal muscular atrophy Pathogenesis Pathology Diagnosis
  • 相关文献

参考文献2

二级参考文献20

  • 1[1]Lefebvre S, Burglen L, Reboullet S, et al . Identification and characterization of a spinal muscular atrophy detemining gene[J ]. Cell,1995;80( 1 ): 155~165
  • 2[2]McAndrew PE, Parsons DW, Simard LR, et al . Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number[J]. Am J Hum G enet, 1997;60(6): 1411~1422
  • 3[3]Monani UR, Lorson CL, Parsons DW, et al . Single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2 [J]. Hum Mol Genet, 1999 ;8 (7):1177~1183
  • 4[4]Echaniz-Laguna A, Miniou P, Bartholdi D, et al . The promoters of the survival motor neuron gene(SMN) and its copy(SMNC) share common regulatory dements[J]. Am J Hum Genet, 1999;64(6):1365~1370
  • 5[5]Andreassi C, Jarecki J, Zhou J, et al . Aclarubicin treatment restores SMN levels to cells derived from type Ⅰ spinal muscular atrophy patients[J ]. Hum Mol Genet, 2001; 10(24) :2841~2849
  • 6[6]Lefebvre S, Burlet P, Viollet L, et al . A novel association of the SMN protein with two major non-ribosomal nucleolar proteins and its implication in spinal muscular atrophy[J ]. Hum Mol Genet, 2002; 11(9): 1017~ 1027
  • 7[7]Munsat TL,Davies KE. International SMA consortium meeting[J].Neuromuscular Disord, 1992;2(5/6) :423~428
  • 8[8]Van der Steege G, Grootscholten PM, van der Vlies P, et al . PCRbased DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy[ J ]. Lancet, 1995; 345 (8955): 985~986
  • 9[9]Nielsen DA, Novoradovsky A, Goldman D, et al . SSCP primer design based on single-strand DNA stucture predicted by a DNA folding program[ J ]. Nucleic Acids Res, 1995 ;23(12) :2287~2291
  • 10[10]Furuwatari C, Yagi A, Yamagami O, et al . A comprehensive system to explore p53 mutations[J]. Am J Clin Pathol, 1998; 110(3):368~373

共引文献8

同被引文献16

  • 1Lunn MR, Wang CH. Spinal muscular atrophy[J]. Lancet, 2008,371(9 630):2 120-2 133.
  • 2Arnold WD,Kassar D,Kissel JT. Spinal muscular atrophy: di- agnosis and management in a new therapeutic era[J]. Muscle Nerve, 2015,51 (2):157-167.
  • 3Tisdale S,Pellizzoni L. Disease mechanisms and therapeutic ap- proaches in spinal muscular atrophy[J]. J Neuroscience, 2015, 35(23) :8 691-8 700.
  • 4Wang CH, Winkel RS, Bertini ES, et al. Consensus statement for standard of care in spinal muscular atrophy['J]. J Child Neurol,2007,22(8) :1 027-1 049.
  • 5Fujioka T, Nakano K, Maniwa S. A clinical study of laryngotr- acheal separation in spinal muscular atrophy type I patients [J]. No To Hattatsu,2015,47(5) :360-362.
  • 6Imlaeh WL, Beck ES,Choi BJ, et al. SMN is required for senso- ry-motor circuit function in Drosophila[J ]. Cell, 2012,151 (2) : 427-439.
  • 7McAndrew PE, Parsons DW, Simard LR, et al. Identification of Proximal Spinal Muscular Atrophy Carriers and Patients by A- nalysis of SMN T and SMN C Gene Copy Number[J]. Am J Hum Genet,1997,60(6):1 411-1 422.
  • 8Wirth B,Brichta L, Schrank B, et al. Mildly affected patients with spinal muscular atrophy are partially protected by an in- creased SMN2 copy number [J]. Human Genetics, 2006, 119(4) : 422-428.
  • 9Lefebvre S, Biirglen L, Rehoullet S, et al. Identi{ication and characterization of a spinal muscular atrophy-determining gene [J]. Cell, 1995,80(1) : 155-165.
  • 10Daguenet E, Dujardin G, Valcdrcel J. The pathogenicity of splicing defects: mechanistic insights into pre-mRNA pro cessing inform novel therapeutic approaches[J]. Embo Re- ports,2015,16(12):1 640-1 655.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部